Endometrial Carcinoma

  • Robert J. Kurman
  • Henry J. Norris


Endometrial carcinoma has become the most common invasive neoplasm of the female genital tract in the United States. In 1984 there were an estimated 39,000 new cases and 2900 deaths from endometrial cancer.161 A rising incidence has been observed also in Canada and western and eastern Europe.11,92,182 There is a much lower incidence in Asia, Africa, and South America than in North America.43 Migration studies of Japanese women who have a low incidence of endometrial cancer in Japan show an increase in the rates of endometrial carcinoma in first and second generations born in California.66 These findings have been attributed to the high content of animal fat in the Western diet,64 but this does not explain the dramatic rise in the incidence of endometrial carcinoma in the United States and Europe.


Endometrial Cancer Endometrial Carcinoma Clear Cell Carcinoma Serous Carcinoma Myometrial Invasion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aikawa M, Ab P (1973) Mixed (adenosquamous) carcinoma of the endometrium. Electron microscopic observations. Cancer 31: 385Google Scholar
  2. 2.
    Alberhasky RC, Connelly PJ, Christopherson WM (1982) Carcinoma of the endometrium. IV. Mixed adenosquamous carcinoma. A clinical-pathological study of 68 cases with long-term follow-up. Am J Clin Pathol 77: 655PubMedGoogle Scholar
  3. 3.
    Alders JG, Abeler V, Kolstad P (1984) Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients. Gynecol Oncol 17: 64Google Scholar
  4. 4.
    Alders JG, Abeler V, Kolstad P (1982) Recurrent carcinoma of the endometrium: A clinical and pathological study of 379 patients. Gynecol Oncol 17: 85Google Scholar
  5. 5.
    Alders JG, Abeler V, Kolstad P (1982) Stage IV endometrial carcinoma: A clinical and pathological study of 83 patients. Gynecol Oncol 17: 75Google Scholar
  6. 6.
    Atkin NB (1976) Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus. J Natl Cancer Inst 56: 909PubMedGoogle Scholar
  7. 7.
    Austin JH, MacMahon B (1969) Indicators of prognosis in carcinoma of the corpus uteri. Surg Gynecol Obstet 128: 1247PubMedGoogle Scholar
  8. 8.
    Aycock NB, Jollie WP, Dunn LJ (1979) An ultrastructural comparison of human endometrial adenocarcinoma with normal postmenopausal endometrium. Obstet Gynecol 53: 565PubMedGoogle Scholar
  9. 9.
    Bannatyne P, Russell P, Wills EJ (1983) Argyrophilia and endometrial carcinoma. Int J Gynecol Pathol 2: 235PubMedGoogle Scholar
  10. 10.
    Barsky SH, Rao CN, Grotendorst GR, Liotta LA (1982) Increased content of type V collagen in desmoplasia of human breast carcinoma. Am J Pathol 108: 276PubMedGoogle Scholar
  11. 11.
    Bean HA, Bryant AJS, Carmichael JA, et al. (1978) Carcinoma of the endometrium in Saskatchewan: 1966 to 1971. Gynecol Oncol 6: 503PubMedGoogle Scholar
  12. 12.
    Beck RP, Latour, JPA (1963) Necropsy reports on 36 cases of endometrial carcinoma. Am J Obstet Gynecol 85: 307PubMedGoogle Scholar
  13. 13.
    Beckner ME, Mori T, Silverberg SG (1985) Endometrial carcinoma: Nontumor factors in prognosis. Int J Gynecol Pathol 4: 131Google Scholar
  14. 14.
    Beller U, Beckman M, Twombly GH (1984) Spontaneous regression of advanced endometrial carcinoma. Gynecol Oncol 17: 381PubMedGoogle Scholar
  15. 15.
    Bigelow B, Vekshtein V, Demopoulis RI (1983) Endome trial carcinoma, stage II: Route and extent of spread to the cervix. Obstet Gynecol 62: 363Google Scholar
  16. 16.
    Blaustein A, Bigelow B, Demopoulis RI (1978) Association of carcinoma of the breast with adenosquamous carcinoma of the endometrium. Cancer 42: 326PubMedGoogle Scholar
  17. 17.
    Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10PubMedGoogle Scholar
  18. 18.
    Bolt HM, Gobel P (1976) Formation of estrogens from androgens by human subcutaneous adipose tissue in vitro. Horm Metal) Res 4: 312Google Scholar
  19. 19.
    Boronow RC (1976) Endometrial cancer: Not a benign disease. Obstet Gynecol 47: 630PubMedGoogle Scholar
  20. 20.
    Boronow RC, Morrow CP, Creasman WT, DiSaia PJ, Silverberg SG, Miller A, Blessing JA (1984) Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstet Gynecol 63: 825Google Scholar
  21. 21.
    Buehl IA, Vellios F, Carter JE, Huber CP (1964) Carcinoma in situ of the endometrium. Am J Clin Pathol 42: 594PubMedGoogle Scholar
  22. 22.
    Bunker M (1959) The terminal findings in endometrial carcinoma. Am J Obstet Gynecol 77: 530PubMedGoogle Scholar
  23. 23.
    Cavazos F, Lucas FV (1973) Ultrastructure of the endometrium. In: Norris HJ, Hertig AT, Abel MR (eds) The uterus. Baltimore, Williams & Wilkins Co., p 136Google Scholar
  24. 24.
    Chan L, O’Malley BW (1976) Mechanism of action of the sex steroid hormones. N Engl J Med 294: 1322PubMedGoogle Scholar
  25. 25.
    Charles D (1967) Endometrial adenoacanthoma. A clinicopathologic study of 55 cases. Cancer 18: 737Google Scholar
  26. 26.
    Chen J, Trost DC, Wilkinson EG (1985) Endometrial papillary adenocarcinomas: Two clinicopathologic types. Int J Gynecol Pathol 4: 279Google Scholar
  27. 27.
    Cheon HK (1969) Prognosis of endometrial carcinoma. Obstet Gynecol 34: 680PubMedGoogle Scholar
  28. 28.
    Christopherson WM, Alberhasky RC, Connelly PJ (1982) Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma. Cancer 49: 1511Google Scholar
  29. 29.
    Christopherson WM, Alberhasky RC, Connelly PJ (1982) Glassy cell carcinoma of the endometrium. Hum Pathol 13: 421Google Scholar
  30. 30.
    Christopherson WM, Alberhasky RC, Connelly PJ (1982) Carcinoma of the endometrium. II. Papillary adenocarcinoma: A clinical pathological study of 46 cases. Am J Clin Pathol 77: 534PubMedGoogle Scholar
  31. 31.
    Christopherson WM, Connelly PJ, Alberhasky RC (1983) Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease. Cancer 51: 1705Google Scholar
  32. 32.
    Cohen C, Shulman G, Budgeon LR (1982) Endocervical and endometrial adenocarcinoma. An immunoperoxidase and histochemical study. A J Surg Pathol 6: 151Google Scholar
  33. 33.
    Connelly PJ, Alberhasky RC, Christopherson WM (1982) Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet Gynecol 59: 569PubMedGoogle Scholar
  34. 34.
    Conney AH (1967) Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 19: 317PubMedGoogle Scholar
  35. 35.
    Cowles TA, Magrina JF, Masterson BJ, et al. (1985) Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstet Gynecol 66: 413PubMedGoogle Scholar
  36. 36.
    Creasman WT, McCarty KS Sr, Barton TK, McCarty KS Jr (1980) Clinical correlates of estrogen and progesterone-binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 55: 363PubMedGoogle Scholar
  37. 37.
    Creasman WT, DiSaia PJ, Blessing J, et al. (1981) Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 141: 921PubMedGoogle Scholar
  38. 38.
    Creasman WT, Soper JT, McCarty KS Jr, McCarty KS Sr, Hinshaw W, Clarke-Pearson DL (1985) Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol 151: 922PubMedGoogle Scholar
  39. 39.
    Cullen TS (1900) Cancer of the uterus: Its pathology, symptomatology, diagnosis and treatment. New York, D. Appleton, p 374Google Scholar
  40. 40.
    Czernobilsky B, Katz Z, Lancet M, Galton E (1980) Endocervical-type epithelium in endometrial carcinoma. A report of 10 cases with emphasis on histochemical methods for differential diagnosis. Am J Surg Pathol 4: 481PubMedGoogle Scholar
  41. 41.
    Deligdisch L, Cohen CJ (1985) Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer 56: 1452PubMedGoogle Scholar
  42. 42.
    DiSaia PJ, Creasman WT, Boronow MD, Blessing JA (1985) Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol 151: 1009PubMedGoogle Scholar
  43. 43.
    Doll R, Muir C, Waterhouse J (1970) Cancer incidence in five continents. International Union Against Cancer. Berlin, Springer-Verlag, Vol 2Google Scholar
  44. 44.
    Donaldson ES, van Nagell JR Jr, Pursell S, Gay EC, Mecker WR, Kashmiri R, Van de Voorde J (1980) Multiple biochemical markers in patients with gynecologic malignancies. Cancer 45: 948PubMedGoogle Scholar
  45. 45.
    Dunn LJ, Merchant JA, Bradbury JT, Stone DB (1968) Glucose tolerance and endometrial cancer: A controlled study. Arch Intern Med 121: 246Google Scholar
  46. 46.
    Dutra F (1959) Intraglandular morules of the endometrium. Am J Clin Pathol 31: 60PubMedGoogle Scholar
  47. 47.
    Ehrlich CE, Young PCM, Cleary RE (1981) Cytoplasmic progesterone receptors in normal, hyperplastic, and carcinomatous endometrium: Therapeutic implications. Am J Obstet Gynecol 141: 539Google Scholar
  48. 48.
    Eifel P, Hendrickson M, Ross J, et al. (1982) Simultaneous presentation of carcinoma involving the ovary and uterine corpus. Cancer 50: 163PubMedGoogle Scholar
  49. 49.
    Elton NW (1942) Morphologic variations in adenocarcinoma of the fundus of the uterus, with reference to secretory activity and clinical interpretations. Am J Clin Pathol 12: 32Google Scholar
  50. 50.
    Factor SM (1974) Papillary adenocarcinoma of the endometrium with psammoma bodies. Arch Pathol 98: 201PubMedGoogle Scholar
  51. 51.
    Fasske E, Morgenroth K, Theman H, Verhagen A (1965) Vegleichende elektronmikroskopishe untersuchungen von proliferationsphase glandular cystischer hyperplasie and adenocarcinom der schleimhaut des corpus uteri. Arch Gynaekol 200: 473Google Scholar
  52. 52.
    Ferenczy A (1980) Morphological effects of exogenous gestagens on abnormal human endometrium. In: DallenbachHellweg G (ed) Functional morphologic changes in femaleGoogle Scholar
  53. sex organs induced by exogenous hormones. Berlin, Heidelberg, New York, Springer-Verlag, p 101Google Scholar
  54. 53.
    Fluhmann CF (1928) Squamous epithelium in the endometrium in benign and malignant conditions. Surg Gynecol Obstet 47: 309Google Scholar
  55. 54.
    Franks AL, Kendrick JS, Tyler CW Jr (1987) Postmenopausal smoking, estrogen replacement therapy and the risk of endometrial cancer. Am J Obstet Gynecol 156: 20PubMedGoogle Scholar
  56. 55.
    Frick HC, Munnell EW, Richart RM, Berger AP, Lawry MF (1973) Carcinoma of the endometrium. Am J Obstet Gynecol 115: 663PubMedGoogle Scholar
  57. 56.
    Fu YS, Parks PJ, Reagen JW, Wentz WB, Storaasli JP (1979) The ultrastructure and factors relating to survival of endometrial cancers. Am J Diag Gynecol Obstet 1: 55Google Scholar
  58. 57.
    Glicksman AS, Rawson RW (1956) Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer 9: 1127PubMedGoogle Scholar
  59. 58.
    Gompel C (1971) Ultrastructure of endometrial carcinoma: Review of 14 cases. Cancer 28: 745PubMedGoogle Scholar
  60. 59.
    Gould VE, Sommers SC, Terzakis JA (1976) Squamous differentiation and basal lamina deposition in endometrial adenoacanthoma. Am J Pathol 84: 25PubMedGoogle Scholar
  61. 60.
    Gray LA, Christopherson WM, Hoover RN (1977) Estrogens and endometrial carcinoma. Obstet Gynecol 49: 385PubMedGoogle Scholar
  62. 61.
    Gray LA, Robertson RW, Christopherson WM (1971) Atypical endometrial changes associated with carcinoma. Gynecol Oncol 2: 93Google Scholar
  63. 62.
    Greenwald P, Caputo TA, Wolfgang PE (1977) Endometrial cancer after menopausal use of estrogens. Obstet Gynecol 50: 239PubMedGoogle Scholar
  64. 63.
    Gurpide E, Tseng L, Gusberg SB (1977) Estrogen metabolism in normal and neoplastic endometrium. Am J Obstet Gynecol 129: 809PubMedGoogle Scholar
  65. 64.
    Gusberg SB (1980) Current concepts in cancer. The changing nature of endometrial cancer. N Engl J Med 302: 729PubMedGoogle Scholar
  66. 65.
    Gusberg SB, Kaplan AL (1963) Precursors of corpus cancer. IV. Adenomatous hyperplasia as stage 0 carcinoma of the endometrium. Am J Obstet Gynecol 87: 662PubMedGoogle Scholar
  67. 66.
    Haenszel W, Kurihara M (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43Google Scholar
  68. 67.
    Hahnel R, Martin JD, Masters AM, Ratajczak T, Twaddle E (1979) Estrogen receptors and blood hormone levels in endometrial carcinoma. Gynecol Oncol 8: 209PubMedGoogle Scholar
  69. 68.
    Hall JB, Young RH, Nelson JH (1984) The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 17: 32PubMedGoogle Scholar
  70. 69.
    Hameed K, Morgan DA (1972) Papillary adenocarcinoma of endometrium with psammoma bodies: Histology and fine structure. Cancer 29: 1326Google Scholar
  71. 70.
    Hanson MB, van Nagell JR Jr, Powell DE, Donaldson ES, Gallion H, Merhige M, Pavlik EJ (1985) The prognostic significance of lymph-vascular space invasion in stageGoogle Scholar
  72. I endometrial cancer. Cancer 55: 1753Google Scholar
  73. 71.
    Hendrickson E (1975) The lymphatic dissemination in endometrial carcinoma. A study of 188 necropsies. AmGoogle Scholar
  74. J Obstet Gynecol 123: 570Google Scholar
  75. 72.
    Hendrickson MR, Kempson RL (1983) Ciliated carcinoma-A variant of endometrial adenocarcinoma: A report of 10 cases. Int J Gynecol Pathol 2: 1PubMedGoogle Scholar
  76. 73.
    Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R (1982) Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6: 93Google Scholar
  77. 74.
    Hernandez E, Woodruff JD (1980) Endometrial adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol 138: 827PubMedGoogle Scholar
  78. 75.
    Hertig AT, Gore H (1960) Atlas of tumor pathology, Section IX-Fascicle 33. Tumors of the female sex organs. Part 2 with supplement. Tumors of the vulva, vagina, and uterus. Washington, D.C., Armed Forces Institute of Pathology, pp 177–258Google Scholar
  79. 76.
    Homesley HD, Boronow RC, Lewis JL Jr (1976) Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospital, 1949–1965. Obstet Gynecol 47: 100PubMedGoogle Scholar
  80. 77.
    Horowitz KB, McGuire WL (1978) Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem 253: 2223Google Scholar
  81. 78.
    Hustin J (1973) Hormonal therapy on endometrial cancer: Effects of large doses given by parenteral or intracavity routes. In: Brush MG, Taylor RW, Williams DC (eds) Symposium on endometrial cancer. London, Cassell Ltd, p 246Google Scholar
  82. 79.
    Hustin J (1978) Immunohistochemical demonstration of several tumour markers in neoplastic and preneoplastic states of the uterine mucosa. Gynecol Obstet Invest 9: 3PubMedGoogle Scholar
  83. 80.
    Iozzo RV (1984) Proteoglycans and neoplastic-mesenchymal cell interactions. Hum Pathol 15: 2PubMedGoogle Scholar
  84. 81.
    Iozzo RV, Bolender RP, Wight TN (1982) Proteoglycan changes in the intercellular matrix of human colon carcinoma: An integrated biochemical and stereologic analysis. Lab Invest 47: 124Google Scholar
  85. 82.
    Janne O, Kauppila A, Kontula K, Syrjala P, Vihko R (1979) Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration. Int J Cancer 24: 545Google Scholar
  86. 83.
    Jenson EF (1984) Intracellular localization of estrogen receptors: Implications for interaction mechanisms. Lab Invest 51: 487Google Scholar
  87. 84.
    Jones HW III (1975) Treatment of adenocarcinoma of the endometrium. Obstet Gynecol Sury 30: 147Google Scholar
  88. 85.
    Julian CG, Daikoku NH, Gillespie A (1977) Adenoepidermoid and adenosquamous carcinoma of the uterus. A clinicopathologic study of 118 cases. Am J Obstet Gynecol 128: 106PubMedGoogle Scholar
  89. 86.
    Kadar RD, Kohorn EI, LiVolsi VA, Kapp DS (1982) Histologic variants of cervical involvement by endometrial carcinoma. Obstet Gynecol 59: 85PubMedGoogle Scholar
  90. 87.
    Kanbour AI, Stock RJ (1978) Squamous cell carcinoma in situ of the endometrium and fallopian tube as superficial extension of invasive cervical carcinoma. Cancer 42: 570PubMedGoogle Scholar
  91. 88.
    Karpas CM, Bridge MR (1963) Endometrial carcinoma with psammomatous bodies. Am J Obstet Gynecol 87: 935PubMedGoogle Scholar
  92. 89.
    Keller D, Kempson RL, Levine G, McLennan C (1974) Management of the patient with early endometrial carcinoma. Cancer 33: 1108PubMedGoogle Scholar
  93. 90.
    King A, Seraj IM, Wagner RJ (1984) Stromal invasion in endometrial carcinoma. Am J Obstet Gynecol 149: 10PubMedGoogle Scholar
  94. 91.
    Kirkpatrick JB (1967) Pathogenesis of foam cell lesions in irradiated arteries. Am J Pathol 50: 291PubMedGoogle Scholar
  95. 92.
    Kjellgren O (1977) Epidemiology and pathophysiology of corpus carcinoma. Acta Obstet Gynecol Scand [Suppl] 65: 77Google Scholar
  96. 93.
    Kjorstad KE, Orjaseter H (1977) Studies on carcinoembryonic antigen levels in patients with adenocarcinoma of the uterus. Cancer 40: 2953PubMedGoogle Scholar
  97. 94.
    Kohorn EI (1976) Gestagens and endometrial carcinoma. Gynecol Oncol 4: 398PubMedGoogle Scholar
  98. 95.
    Koller O (1964) Results of treatment of adenocarcinoma of the uterine body. Natl Cancer Inst Monogr 15: 99PubMedGoogle Scholar
  99. 96.
    Kottmeier HL (ed) (1979) Annual report on the results of treatment in gynecologic cancer. Stockholm, Sweden, International Federation of Gynecology and Obstetrics, Vol 17Google Scholar
  100. 97.
    Kraus FT (1973) Irradiation changes in the uterus. In: Norris HJ, Hertig AT, Abell MR (eds) The uterus. Baltimore, William & Wilkins Co., p 457Google Scholar
  101. 98.
    Kumar A, Schneider V (1983) Metastases to the uterus from extrapelvic primary tumors. Int J Gynecol Pathol 2: 134PubMedGoogle Scholar
  102. 99.
    Kumar NB, Hart WR (1982) Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer 50: 2163PubMedGoogle Scholar
  103. 100.
    Kurman RJ, Norris HJ (1982) Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49: 2547.PubMedGoogle Scholar
  104. 101.
    Kurman RJ, Norris HJ (1986) Precursors of endometrial cancer. In: Henson DE, Albores, Savedra JA (eds) Pathology of incipient neoplasia. Philadelphia, W. B. Saunders Co.Google Scholar
  105. 102.
    Kurman RJ, Scully RE (1976) Clear cell carcinoma of the endometrium. An analysis of 21 cases. Cancer 37: 872PubMedGoogle Scholar
  106. 103.
    Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 56: 403PubMedGoogle Scholar
  107. 104.
    Lauchlan SC (1968) Conceptual unity of the müllerian tumor group. Cancer 22: 601PubMedGoogle Scholar
  108. 105.
    Lauchlan SC (1981) Tubal (serous) carcinoma of the endometrium. Arch Pathol 105: 615Google Scholar
  109. 106.
    Lesko SM, Rosenberg L, Kaufman DW, et al. (1985) Cigarette smoking and the risk of endometrial cancer. N Engl J Med 313: 593PubMedGoogle Scholar
  110. 107.
    Lewis BV, Stallworthy JA, Cowdell R (1970) Adenocarcinoma of the body of the uterus. J Obstet Gynaecol Br Commonw 77: 343PubMedGoogle Scholar
  111. 108.
    Lindahl B, Alm P, Ferno M, Norgren A, Trope C (1984) Plasma steroid hormones, cytosol receptors, and thymidine incorporation rate in endometrial carcinoma. Am J Obstet Gynecol 149: 607PubMedGoogle Scholar
  112. 370.
    Robert J. Kurman and Henry J. NorrisGoogle Scholar
  113. 109.
    Liotta LA, Rao CN, Barsky SH (1983) Tumor invasion and the extracellular matrix. Lab Invest 49: 636PubMedGoogle Scholar
  114. 110.
    Liu CT (1972) A study of endometrial adenocarcinoma with emphasis on morphologically variant types. Am J Clin Pathol 57: 562PubMedGoogle Scholar
  115. 111.
    LiVolsi VA (1977) Adenocarcinoma of the endometrium with psammoma bodies. Obstet Gynecol 50: 725PubMedGoogle Scholar
  116. 112.
    Longscope C, Pratt JH, Schneider SH, Fineberg SE (1978) Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metabl 46: 146Google Scholar
  117. 113.
    Lucas WE, Yen SSC (1979) A study of endocrine and metabolic variables in postmenopausal women with endometrial carcinoma. Am J Obstet Gynecol 134: 180PubMedGoogle Scholar
  118. 114.
    Lutz MH, Underwood PB Jr, Kreutner A Jr, et al. (1978) Endometrial carcinoma: A method of classification of therapeutic and prognostic significance. Gynecol Oncol 6: 83Google Scholar
  119. 115.
    Lynch HT, Krush AH, Larsen AL (1967) Heredity and endometrial carcinoma. South Med J 60: 231PubMedGoogle Scholar
  120. 116.
    Mack TM, Pike MC, Henderson BE, Pfeffer RI, Gerkins VR, Arthur M, Brown SE (1976) Estrogens and endometrial cancer in a retirement community. N Engl J Med 294: 1262PubMedGoogle Scholar
  121. 117.
    Mahle A (1923) The morphological histology of adenocarcinoma of the body of the uterus in relation to longevity. Surg Gynecol Obstet 36: 385Google Scholar
  122. 118.
    Martin JD, Hahnel R, McCartney AJ, Woodings TL (1983) The effect of estrogen receptor status on survival in patients with endometrial cancer. Am J Obstet Gynecol 147: 322PubMedGoogle Scholar
  123. 119.
    Mazur MT (1981) Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 5: 473PubMedGoogle Scholar
  124. 120.
    McCarty KS Jr, Barton TK, Fetter BF, Creasman WT, McCarty KS Sr (1979) Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. Am J Pathol 96: 171PubMedGoogle Scholar
  125. 121.
    McDonald TW, Annegers JF, O’Fallon WM, Dockerty MB, Malkasian GD, Kurland LT (1977) Exogenous estrogen and endometrial carcinoma: Case-control and incidence study. Am J Obstet Gynecol 127: 572Google Scholar
  126. 122.
    Melin JR, Wanner L, Schulz DM, Cassel EE (1979) Primary squamous cell carcinoma of the endometrium. Ob-stet Gynecol 53: 115Google Scholar
  127. 123.
    Michael H, Grawe L, Kraus FT (1984) Minimal deviation endocervical adenocarcinoma: Clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions. Int J Gynecol Pathol 3: 261Google Scholar
  128. 124.
    Moberger B, Forsslun AG, Moberger G (1984) The prognostic significance of DNA measurements in endometrial carcinoma Cytometry 5: 430Google Scholar
  129. 125.
    Morrow CP, DiSaia PJ, Townsend DE (1973) Current management of endometrial carcinoma. Obstet Gynecol 42: 399PubMedGoogle Scholar
  130. 126.
    Muechler EK, Flickinger GL, Mangan CE, Mikhail G (1975) Estradiol binding by human endometrial tissue. Gynecol Oncol 3: 244PubMedGoogle Scholar
  131. 127.
    Musubuchi K, Nemoto H (1972) Epidemiologic studies on uterine cancer at Cancer Institute Hospital, Tokyo, Japan. Cancer 30: 268Google Scholar
  132. 128.
    Nahhas WA, Lund CJ, Rudolph JH (1971) Carcinoma of the corpus uteri: A 10-year review of 225 patients. Obstet Gynecol 38: 564PubMedGoogle Scholar
  133. 129.
    Ng ABP (1968) Mixed carcinoma of the endometrium. Am J Obstet Gynecol 102: 506PubMedGoogle Scholar
  134. 130.
    Ng ABP, Reagan JW (1970) Incidence and prognosis of endometrial carcinoma by histologic grade and extent. Obstet Gynecol 35: 437PubMedGoogle Scholar
  135. 131.
    Ng ABP, Reagan JW, Storaasli JP, Wentz WB (1973) Mixed adenosquamous carcinoma of the endometrium. Am J Clin Pathol 59: 765PubMedGoogle Scholar
  136. 132.
    Nilsson O (1962) Electron microscopy of human endometrial carcinoma. Cancer Res 22: 491Google Scholar
  137. 133.
    Nimrod A, Ryan KJ (1975) Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab 40: 367PubMedGoogle Scholar
  138. 134.
    Novak ER, Nalley WB (1957) Uterine adenoacanthoma. Obstet Gynecol 9: 396PubMedGoogle Scholar
  139. 135.
    Peterson EP (1968) Endometrial carcinoma in young women. A clinical profile. Obstet Gynecol 31: 702PubMedGoogle Scholar
  140. 136.
    Piver MS, Lele S, Barlow J, et al. (1982) Paraaortic lymph node evaluation in stage I endometrial cancer. Obstet Gynecol 59: 97PubMedGoogle Scholar
  141. 137.
    Preen KA, Mensheha NM, McKelvey JL (1965) Operative treatment in adenocarcinoma of the endometrium in obese women. Am J Obstet Gynecol 92: 16Google Scholar
  142. 138.
    Press MF, Nousek-Goebel N, Greene, GL (1985) Immunoelectron microscopic localization of estrogen receptor with monoclonal estrophilin antibodies. J Histochem Cytochem 33: 915PubMedGoogle Scholar
  143. 139.
    Press MF, Nousek-Goebel N, King WJ, Herbst AL, Greene GL (1984) Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle. Lab Invest 51: 495PubMedGoogle Scholar
  144. 140.
    Reifenstein EC Jr (1974) The treatment of advanced endometrial cancer with hydroxyprogesterone caproate. Gynecol Oncol 2: 377PubMedGoogle Scholar
  145. 141.
    Richart RM, Ferenczy A (1974) Endometrial morphologic response to hormonal environment. Gynecol Oncol 2: 180PubMedGoogle Scholar
  146. 142.
    Risberg B, Grotoft O, Westholm B (1983) Origin of carcinoma in secretory endometrium-A study using a whole organ sectioning technique. Gynecol Oncol 15: 32PubMedGoogle Scholar
  147. 143.
    Robboy SJ, Bradley R (1979) Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy. Obstet Gynecol 54: 269PubMedGoogle Scholar
  148. 144.
    Robboy SJ, Miller AW III, Kurman RJ (1982) The pathologic features and behavior of endometrial carcinoma associated with exogenous estrogen administration. Pathol Res Pract 174: 237PubMedGoogle Scholar
  149. 145.
    Roberts DWT (1961) Carcinoma of the body of the uterus at Chelsea Hospital for Women, 1943–1953. J Obstet Gynaecol Br Commonw 68: 132Google Scholar
  150. 146.
    Rodriguez J, Hart WR (1982) Endometrial cancers occurring 10 or more years after pelvic irradiation for carcinoma. Int J Gynecol Pathol 1: 135PubMedGoogle Scholar
  151. 147.
    Rorat E, Ferenczy A, Richart RM (1974) The ultrastructure of clear cell adenocarcinoma of endometrium. Cancer 33: 880PubMedGoogle Scholar
  152. 148.
    Ross J, Eifel PH, Cox RS, Kempson RL, Hendrickson MR (1983) Primary mutinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol 7: 715Google Scholar
  153. 149.
    Salazar OM, DePapp EW, Bonfiglio TA, Feldstein MK, Rubin P, Rudolph JH (1977) Adenosquamous carcinoma of the endometrium. An entity with an inherently poor 169. prognosis? Cancer 40: 119PubMedGoogle Scholar
  154. 150.
    Salazar OM, Feldstein ML, DePapp EW, et al. (1977) Endometrial carcinoma: Analysis of failures with special emphasis on the use of initial preoperative external pelvic 170. radiation. Int J Radiat Oncol Biol Phys 2: 1101PubMedGoogle Scholar
  155. 151.
    Salazar OM, Feldstein ML, DePapp EW, et al. (1978) The management of clinical stage I endometrial carcinoma. Cancer 41: 1016 171.Google Scholar
  156. 152.
    Salm R (1962) Mucin production of normal and abnormal endometrium. Arch Pathol 73: 30 172.Google Scholar
  157. 153.
    Sato N, Mori T, Orenstein JM, Silverberg SG (1984) Ultra-structure of papillary serous carcinoma of the endometrium. Int J Gynecol Pathol 2: 337 173.Google Scholar
  158. 154.
    Schenker JG (1980) Adenocarcinoma of the endometrium in Israel, 1960–1968. Cancer 46: 2752PubMedGoogle Scholar
  159. 155.
    Schenker JG, Weinstein D, Okon E (1979) Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer. Cancer 44: 1809PubMedGoogle Scholar
  160. 156.
    Scully RE, Aguirre P, DeLellis RA (1984) Argyrophilia, serotonin, and peptide hormones in the female genital tract and its tumors. Int J Gynecol Pathol 3: 51PubMedGoogle Scholar
  161. 157.
    Scully RE, Richardson G, Barlow JF (1966) The development of malignancy in endometriosis. Clin Obstet Gynecol 9: 384PubMedGoogle Scholar
  162. 158.
    Seemayer TA, Schurch W, Lagace R, Tremblay G (1979) Myofibroblasts in the stroma of invasive and metastatic carcinoma. Am J Surg Pathol 3: 525PubMedGoogle Scholar
  163. 159.
    Sekiya S, Takeda B, Kikuchi Y, Sakaguchi S, Takamizawa H (1977) Morphologic and enzyme-cytochemical changes in uterine adenocarcinoma cells of a rat by direct application of progesterone in vitro. Gynecol Oncol 5: 5PubMedGoogle Scholar
  164. 160.
    Seppala M, Pihko H, Ruoslahti E (1975) Carcinoembryonic antigen and alpha-fetoprotein in malignant tumors of the female genital tract. Cancer 35: 1377PubMedGoogle Scholar
  165. 161.
    Silverberg E (1984) Cancer Statistics. 34: 7Google Scholar
  166. 162.
    Silverberg SG (1981) Significance of squamous elements in carcinoma of the endometrium: A review. Prog Surg Pathol 4: 115Google Scholar
  167. 163.
    Silverberg SG, De Giorgi LS (1973) Clear cell carcinoma of the endometrium: Clinical, pathologic, and ultrastructural findings. Cancer 31: 1127Google Scholar
  168. 164.
    Silverberg SG, Bolin MG, De Giorgi LS (1972) Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium: A clinicopathologic study. Cancer 30: 1307Google Scholar
  169. 165.
    Silverberg SG, Sasano N, Yajima A (1982) Endometrial carcinoma in Miyagi Prefecture, Japan: Histopathologic analysis of a cancer-based series and comparison with cases in American women. Cancer 49: 1504Google Scholar
  170. 166.
    Silverberg SG, Mullen D, Faraci JA, Makowski EL, Miller A, Finch JL, Sutherland JV (1980) Endometrial carcinoma: Clinical-pathologic comparison of cases in postmenopausal women receiving and not receiving estrogens. Cancer 45: 3018Google Scholar
  171. 167.
    Smith DC, Prentice R, Thompson DJ, Hermann WL (1975) Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293: 1164PubMedGoogle Scholar
  172. 168.
    Smith M, McCartney AJ (1985) Occult, high-risk endometrial cancer. Gynecol Oncol 22: 154PubMedGoogle Scholar
  173. 169.
    Speers WC, Picaso LG, Silverberg SG (1983) Immunohistochemical localization of carcinoembryonic antigen in microglandular hyperplasia and adenocarcinoma of the endocervix. Am J Clin Pathol 79: 105PubMedGoogle Scholar
  174. 170.
    Steinhorn SC, Myers MH, Hankey BF, Pelham VF (1986) Factors associated with survival differences between black and white women with cancer of the uterine corpus. Am J Epidemiol 124: 85PubMedGoogle Scholar
  175. 171.
    Suit HD, Gallagher HS (1964) Intact tumor cells in irradiated tissue. Arch Pathol 78: 648PubMedGoogle Scholar
  176. 172.
    Tavassoli F, Kraus FT (1978) Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am J Clin Pathol 70: 770PubMedGoogle Scholar
  177. 173.
    Thrasher TV, Richart RM (1972) An ultrastructural comparison of endometrial adenocarcinoma and normal endometrium. Cancer 29: 1713PubMedGoogle Scholar
  178. 174.
    Tiltman AJ (1980) Mucinous carcinoma of the endometrium. Obstet Gynecol 55: 244PubMedGoogle Scholar
  179. 175.
    Tobon H, Watkins GJ (1985) Secretory adenocarcinoma of the endometrium. Int J Gynecol Pathol 4: 328PubMedGoogle Scholar
  180. 176.
    Tubiana M (1971) The kinetics of tumour cell proliferation and radiotherapy. Br J Radiol 44: 325PubMedGoogle Scholar
  181. 177.
    Ueda G, Yamasaki M, Inoue M, Kurachi K (1979) A clinicopathologic study of endometrial carcinomas with argyrophil cells. Gynecol Oncol 7: 223PubMedGoogle Scholar
  182. 178.
    Ueda G, Sato Y, Yamasaki M, et al. (1978) Argyrophil cell adenocarcinoma of the endometrium. Gynecol Oncol 6: 467PubMedGoogle Scholar
  183. 179.
    Ulbright TM, Roth LM (1985) Metastatic and independent cancers of the endometrium and ovary: A clinicopathologic study of 34 cases. Hum Pathol 16: 28PubMedGoogle Scholar
  184. 180.
    van Nagell JR Jr, Donaldson ES, Wood EG, Sharkey RM, Goldenberg DM (1977) The prognostic significance of carcinoembryonic antigen in the plasma and tumors of patients with endometrial adenocarcinoma. Am J Obstet Gynecol 128: 308PubMedGoogle Scholar
  185. 181.
    Wahlstrom T, Korhonen M, Lindgren J, Markku S (1979) Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histologic tissue sections. Lancet 2: 1159PubMedGoogle Scholar
  186. 182.
    Walker AM, Jick H (1979) Cancer of the corpus uteri: Increasing incidence in the United States. Am J Epidemiol 110: 47Google Scholar
  187. 183.
    Walker AM, Jick H (1980) Declining rates of endometrial cancer. Obstet Gynecol 56: 733PubMedGoogle Scholar
  188. 184.
    Warren S (1961) The pathology of ionizing radiation. Springfield, Ill., Charles C ThomasGoogle Scholar
  189. 185.
    Way S (1954) The aetiology of carcinoma of the body of the uterus. J Obstet Gynaecol Br Empire 61: 46Google Scholar
  190. 186.
    Weiner J, Bigelow B, Demopoulis RI (1980) The value of endocervical sampling in the staging of endometrial carcinoma. Diag Gynecol Obstet 2: 265Google Scholar
  191. 187.
    Wentz WB (1964) Effect of a progestational agent on endometrial hyperplasia and endometrial cancer. Obstet Gynecol 24: 370PubMedGoogle Scholar
  192. 188.
    Wessel W (1965) Endometrials adenocarcinome verschiedener differenzierungsgrade und ihr stroma in elektronenmikroskopishen bild. Z Krebsforsch 66: 421PubMedGoogle Scholar
  193. 189.
    Wynder EL, Escher GC, Mantel N (1966) An epidemiological investigation of cancer of the endometrium. Cancer 19: 489PubMedGoogle Scholar
  194. 190.
    Yazigi R, Piver MS, Blumenson L (1983) Malignant peritoneal cytology as a prognostic indicator in stage I endometrial cancer. Obstet Gynecol 62: 359PubMedGoogle Scholar
  195. 191.
    Yoonessi M, Anderson DG, Morley GW (1979) Endometrial carcinoma: Causes of death and sites of treatment failure. Cancer 43: 1944Google Scholar
  196. 192.
    Ziel HK, Finkle WD (1975) Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293: 1167PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Robert J. Kurman
  • Henry J. Norris

There are no affiliations available

Personalised recommendations